Sharesave option grant to Executive Directors

RNS Number : 6000B
Thruvision Group PLC
21 September 2018
 

 

 

21 September 2018

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Sharesave option grant to Executive Directors

 

 

Thruvision (AIM: THRU) the specialist provider of people-screening technology to the international security market, announces a grant of share options under the Thruvision Sharesave scheme (the "Scheme").

 

Earlier today the Remuneration Committee of the Group granted, under the rules of the Scheme, an option over 90,000 Ordinary 1p shares with an exercise price of 20 pence per share to both Tom Black (Executive Chairman) and Colin Evans (Managing Director).

 

The exercise price, set on 28 August 2018, is calculated on the basis of 80% of the closing middle market price of Thruvision shares on 24 August 2018. The option may be exercised between 1 November 2021 and 30 April 2022, assuming the conditions of the Scheme are met.

 

Immediately prior to this grant, neither Tom Black or Colin Evans had any entitlement under the Scheme.

 

 

 

For further information please contact:

 

 

 

Thruvision Group plc

+44 (0) 123 436180

Tom Black, Executive Chairman

 

Colin Evans, Managing Director

 

 

 

Investec Bank plc

+44 (0) 20 7597 5970

Andrew Pinder / Sebastian Lawrence / Patrick Robb

 

 

 

FTI Consulting LLP

+44 (0) 20 3727 1000

Edward Bridges / Matt Dixon / Harry Staight

 

 

 

About Thruvision

Thruvision Group plc is a specialist provider of people-screening technology that can detect weapons, explosives and contraband hidden under clothing. Developed with extensive support from the British and US Governments, Thruvision technology is operationally proven and is being used to enhance the security of transport hubs, borders, high profile buildings and public areas.

 

 

www.thruvision.com 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZFLFLVKFFBBQ
UK 100

Latest directors dealings